Amiodarone
The metabolism of Clindamycin can be decreased when combined with Amiodarone.
Apalutamide
The serum concentration of Clindamycin can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Clindamycin can be increased when it is combined with Aprepitant.
Advertisement
Atazanavir
The metabolism of Clindamycin can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Clindamycin can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Clindamycin is combined with Atorvastatin.
Advertisement
Atracurium
Clindamycin may increase the neuromuscular blocking activities of Atracurium.
Atracurium Besylate
Clindamycin may increase the neuromuscular blocking activities of Atracurium besylate.
Boceprevir
The metabolism of Clindamycin can be decreased when combined with Boceprevir.
Advertisement
Bortezomib
The metabolism of Clindamycin can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Clindamycin can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Clindamycin.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Clindamycin.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Clindamycin.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Clindamycin.
Carbamazepine
The metabolism of Clindamycin can be increased when combined with Carbamazepine.
Ceritinib
The serum concentration of Clindamycin can be increased when it is combined with Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Clindamycin.
Cisatracurium
Clindamycin may increase the neuromuscular blocking activities of Cisatracurium besylate.
Clarithromycin
The metabolism of Clindamycin can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Clindamycin can be decreased when combined with Clemastine.
Clotrimazole
The metabolism of Clindamycin can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Clindamycin can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Clindamycin.
Crizotinib
The metabolism of Clindamycin can be decreased when combined with Crizotinib.
Cyclosporine
The metabolism of Clindamycin can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Clindamycin can be decreased when it is combined with Dabrafenib.
Darunavir
The metabolism of Clindamycin can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Clindamycin can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Clindamycin can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Clindamycin can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Clindamycin can be decreased when combined with Delavirdine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Clindamycin.
Diltiazem
The metabolism of Clindamycin can be decreased when combined with Diltiazem.
Doxacurium Chloride
Clindamycin may increase the neuromuscular blocking activities of Doxacurium chloride.
Doxycycline
The metabolism of Clindamycin can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Clindamycin can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Clindamycin can be decreased when combined with Dronedarone.
Enzalutamide
The serum concentration of Clindamycin can be decreased when it is combined with Enzalutamide.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Clindamycin.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Clindamycin.
Erythromycin
The therapeutic efficacy of Clindamycin can be decreased when used in combination with Erythromycin.
Fluconazole
The metabolism of Clindamycin can be decreased when combined with Fluconazole.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Clindamycin.
Fluvoxamine
The metabolism of Clindamycin can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Clindamycin can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Clindamycin can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Clindamycin can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Clindamycin can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Clindamycin can be increased when it is combined with Fusidic Acid.
Gallamine Triethiodide
Clindamycin may increase the neuromuscular blocking activities of Gallamine Triethiodide.
Hypoxis hemerocallidea root extract
The serum concentration of Clindamycin can be decreased when it is combined with St. John's Wort.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Clindamycin.
Idelalisib
The metabolism of Clindamycin can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Clindamycin can be decreased when combined with Imatinib.
Indinavir
The metabolism of Clindamycin can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Clindamycin can be decreased when combined with Indinavir.
Isavuconazole
The serum concentration of Clindamycin can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Clindamycin can be decreased when combined with Isavuconazonium.
Isradipine
The metabolism of Clindamycin can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Clindamycin can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Clindamycin can be increased when it is combined with Ivacaftor.
Kaolin
Kaolin can cause a decrease in the absorption of Clindamycin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Kaolin light
Kaolin can cause a decrease in the absorption of Clindamycin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ketoconazole
The metabolism of Clindamycin can be decreased when combined with Ketoconazole.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Clindamycin.
Lopinavir
The metabolism of Clindamycin can be decreased when combined with Lopinavir.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Clindamycin.
Luliconazole
The serum concentration of Clindamycin can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Clindamycin can be increased when combined with Lumacaftor.
Mecamylamine
Clindamycin may increase the neuromuscular blocking activities of Mecamylamine.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Clindamycin.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Clindamycin.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Clindamycin.
Metocurine
Clindamycin may increase the neuromuscular blocking activities of Metocurine.
Metocurine iodide
Clindamycin may increase the neuromuscular blocking activities of Metocurine Iodide.
Mifepristone
The serum concentration of Clindamycin can be increased when it is combined with Mifepristone.
Mitotane
The serum concentration of Clindamycin can be decreased when it is combined with Mitotane.
Mivacurium
Clindamycin may increase the neuromuscular blocking activities of Mivacurium.
Nefazodone
The metabolism of Clindamycin can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Clindamycin can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Clindamycin can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Clindamycin can be increased when combined with Nevirapine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Clindamycin.
Nilotinib
The metabolism of Clindamycin can be decreased when combined with Nilotinib.
Olaparib
The metabolism of Clindamycin can be decreased when combined with Olaparib.
Osimertinib
The serum concentration of Clindamycin can be increased when it is combined with Osimertinib.
Palbociclib
The serum concentration of Clindamycin can be increased when it is combined with Palbociclib.
Pancuronium
Clindamycin may increase the neuromuscular blocking activities of Pancuronium.
Pancuronium Bromide
Clindamycin may increase the neuromuscular blocking activities of Pancuronium.
Pentobarbital
The metabolism of Clindamycin can be increased when combined with Pentobarbital.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Clindamycin.
Phenobarbital
The metabolism of Clindamycin can be increased when combined with Phenobarbital.
Phenytoin
The metabolism of Clindamycin can be increased when combined with Phenytoin.
Picosulfuric Acid
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Clindamycin.
Pipecuronium
Clindamycin may increase the neuromuscular blocking activities of Pipecuronium.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Clindamycin.
Posaconazole
The metabolism of Clindamycin can be decreased when combined with Posaconazole.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Clindamycin.
Primidone
The metabolism of Clindamycin can be increased when combined with Primidone.
Pyrantel
Clindamycin may increase the neuromuscular blocking activities of Pyrantel.
Ranolazine
The metabolism of Clindamycin can be decreased when combined with Ranolazine.
Rapacuronium
Clindamycin may increase the neuromuscular blocking activities of Rapacuronium.
Rifabutin
The metabolism of Clindamycin can be increased when combined with Rifabutin.
Rifampin
The metabolism of Clindamycin can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Clindamycin can be increased when combined with Rifapentine.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Clindamycin.
Rocuronium
Clindamycin may increase the neuromuscular blocking activities of Rocuronium.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Clindamycin.
Rucaparib
The metabolism of Clindamycin can be decreased when combined with Rucaparib.
Saquinavir
The metabolism of Clindamycin can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Clindamycin can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Clindamycin can be decreased when used in combination with Sarilumab.
Sildenafil
The metabolism of Clindamycin can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Clindamycin can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Clindamycin can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Clindamycin.
ST. JOHN'S WORT EXTRACT
The serum concentration of Clindamycin can be decreased when it is combined with St. John's Wort.
Succinylcholine
Clindamycin may increase the neuromuscular blocking activities of Succinylcholine.
Sulfisoxazole
The metabolism of Clindamycin can be decreased when combined with Sulfisoxazole.
Telaprevir
The metabolism of Clindamycin can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Clindamycin can be decreased when combined with Telithromycin.
Ticlopidine
The metabolism of Clindamycin can be decreased when combined with Ticlopidine.
Tocilizumab
The serum concentration of Clindamycin can be decreased when it is combined with Tocilizumab.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Clindamycin.
Tubocurarine
Clindamycin may increase the neuromuscular blocking activities of Tubocurarine.
Vecuronium
Clindamycin may increase the neuromuscular blocking activities of Vecuronium.
Vemurafenib
The serum concentration of Clindamycin can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Clindamycin can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Clindamycin can be decreased when combined with Verapamil.
Voriconazole
The metabolism of Clindamycin can be decreased when combined with Voriconazole.
Ziprasidone
The metabolism of Clindamycin can be decreased when combined with Ziprasidone.
